4
Changes in Ownership
Lipocine Inc. Filed Acc 0001641172-25-013793
Options or other derivatives
- Director acquired 1,764 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Fink Jeffrey Arvin Director | 2025-06-04 | Grant or award · Common Stock (Right to Buy) | +1,764 | $3.20 | $5,645 | 11,526 | D |
Loading xslF345X05/ownership.xml…